IMNM
Immunome Inc.
+0.70 (+3.01%)24.17USD263K成交股數2.7B市值–本益比(近四季)–股價營收比-100.0%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00-100% | 0.00-100% | 0.00-100% | 4.0M+70% | 2.9M+184% | 2.7M-23% | 2.9M-32% | 2.4M0% | 1.0M | 3.6M | 4.3M | 2.4M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 59.9M | 46.4M | 49.2M | 40.5M | 36.9M | 47.9M | 37.2M | 29.1M | 15.4M | 3.8M | 5.7M | 3.9M |
| 銷售管理費用 | 18.3M | 13.0M | 10.9M | 10.0M | 10.7M | 10.4M | 9.5M | 7.0M | 6.0M | 4.4M | 4.3M | 2.9M |
| 營業利益 | −78.1M+75% | −59.3M-28% | −60.1M+19% | −46.5M+16% | −44.6M-66% | −83.0M+1691% | −50.5M+775% | −40.0M+795% | −132M | −4.6M | −5.8M | −4.5M |
| 營業利益率 | – | – | – | -1,157.6% | -1,525.5% | -3,030.3% | -1,736.2% | -1,692.4% | -12,857.0% | -130.0% | -135.4% | -189.1% |
| 稅後淨利 | −73.1M+76% | −53.8M-33% | −57.5M+22% | −43.4M+20% | −41.6M-68% | −80.2M+1747% | −47.1M+748% | −36.1M+746% | −129M | −4.3M | −5.6M | −4.3M |
| 淨利率 | – | – | – | -1,080.9% | -1,423.1% | -2,930.9% | -1,618.6% | -1,528.0% | -12,584.3% | -121.9% | -130.4% | -180.6% |
| 稀釋 EPS | -0.65+25% | -0.48-57% | -0.65-17% | -0.50-17% | -0.52-79% | -1.11+208% | -0.78+70% | -0.60+71% | -2.51 | -0.36 | -0.46 | -0.35 |
| 稀釋股數 | 113M | 113M | 88.0M | 87.0M | 79.4M | 58.6M | 60.2M | 59.9M | 51.5M | 12.2M | 12.2M | 12.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 218M | 583M | 273M | 144M | 258M | 143M | 156M | 165M | 270M | 90.6M | 38.4M | 44.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 565M | 620M | 299M | 296M | 343M | 240M | 257M | 296M | 320M | 93.2M | 41.4M | 48.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 40.3M | 31.1M | 35.5M | 27.0M | 35.6M | 59.1M | 42.0M | 42.4M | 34.2M | 87.1M | 32.1M | 34.3M |
| 股東權益 | 525M | 589M | 264M | 269M | 307M | 181M | 215M | 254M | 286M | 6.1M | 9.3M | 13.9M |
| 負債比 | 7.1% | 5.0% | 11.8% | 9.1% | 10.4% | 24.6% | 16.3% | 14.3% | 10.7% | 93.5% | 77.5% | 71.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −58.6M | – | – | −53.1M+375% | – | – | – | −11.2M | – | – | 24.2M |
| 資本支出 | – | 3.0M | – | – | 3.7M | – | – | – | 2.2M | – | – | 106K |
| 自由現金流 | – | −61.6M | – | – | −56.7M+325% | – | – | – | −13.3M | – | – | 24.1M |
| 折舊攤銷 | – | 603K | – | – | 611K | – | – | – | 157K | – | – | 94K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | -1,938.5% | – | – | – | -1,295.8% | – | – | 1,018.1% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 6.9M
| Single Reportable | 6.9M | 100.0% | -23.2% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 6.9M | -23.2% | −212M | -3,060.0% | -2.43 | −201M |
| FY2024 | 9.0M | -35.5% | −293M | -3,240.4% | -5.00 | −118M |
| FY2023 | 14.0M | +280260.0% | −107M | -761.9% | -5.38 | −8.4M |
| FY2022 | 5K | -150.0% | −36.9M | -737,920.0% | -3.09 | −28.9M |
| FY2021 | −10K | -73.7% | −24.7M | 247,110.0% | -2.14 | −18.3M |
| FY2020 | −38K | -60.4% | −17.8M | 46,939.5% | -5.26 | −12.7M |
| FY2019 | −96K | – | −10.4M | 10,879.2% | -9.55 | −9.8M |